Vergoeding 2019-2023 voor ATC-subgroep N04BC : Dopamine-agonisten
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N04BC01 Bromocriptine | 3.039 | 440 | . | . | . |
| N04BC04 Ropinirol (Requip ®) | 1.548.500 | 1.439.700 | 1.128.500 | 1.047.900 | 1.242.500 |
| N04BC05 Pramipexol (Sifrol ®) | 4.939.300 | 4.681.700 | 4.495.400 | 4.573.200 | 4.670.900 |
| N04BC07 Apomorfine (Apo-go ®) | 514.010 | 687.290 | 758.300 | 1.069.800 | 1.069.800 |
| N04BC09 Rotigotine (Neupro ®) | 2.520.600 | 2.572.000 | 2.573.600 | 2.640.900 | 2.727.500 |
| Totaal | 9.525.449 | 9.381.130 | 8.955.800 | 9.331.800 | 9.710.700 |